EMBC: Embecta Corp. - Summary | Jitta

Embecta Corp.

NASDAQ:EMBC

Price
$3.03
Loss Chance
46.1%
3.39JITTA SCORE
82.56%Under Jitta Line
Jitta Ranking
422 / 712
3,102 / 4,222
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (14)
Recent Business Performance (50)
Financial Strength (74)
Return to Shareholders (15)
Competitive Advantage (30)
Jitta Signs
CapExVery Low
Revenue and EarningRevenue decline from 2022-2025
Recent Business PerformanceEarning decline 82.03% in the last quarter (yoy)
SG&A to SalesIncreasing
Key Stats
Jitta Score
Jitta Line
3.39
82.56%
3.05
149.23%
Health Care Supplies
6.86
10.81%
5.28
206.55%
4.43
95.20%
COMPANY DESCRIPTION
Embecta Corp., a medical device company, provides solutions to improve the health and wellbeing of people living with diabetes in the United States and internationally. The company’s products include pen needles, syringes, and safety injection devices, as well as digital applications to assist people with managing patient’s diabetes. It primarily sells its products to wholesalers and distributors. The company was formerly known as Berra Newco, Inc. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.